Here are the Form 4 insider transactions from Q/C Technologies, Inc. (QCLS) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow QCLS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full QCLS filings page.
Q/C Technologies, Inc. Executive Chairman Joshua Silverman received two direct restricted-stock grants: 77,390 shares on October 1, 2026, and 16,620 shares on July 10, 2026. Both awards vested under the Compensation Agreement. The agreement associated with the July grant, dated April 13, 2026, provides for quarterly grants equal to $60,000.
Q/C Technologies, Inc. reports that Executive Chairman Joshua Silverman’s April 13, 2026 award was 16,806 restricted stock units (RSUs), correcting the original Form 4’s 162,162-share figure. The RSUs vested immediately upon grant. His corrected common-stock holdings after the transaction are 116,835 shares, revised from 262,191.
The amendment also reports a grant of 100,000 stock options with an exercise price of $5 per share and an expiration date of April 13, 2036. The options are subject to expiration if Silverman ceases to be employed by or provide services to the company.
Q/C TECHNOLOGIES, INC. director Chelsea Sierra Voss reported a small open-market purchase of common stock through a Roth IRA. The filing shows an indirect acquisition of 1,753 shares at $3.15 per share, bringing her Roth IRA holdings to 61,555 shares and her separate direct holdings to 239,900 shares.
Q/C Technologies, Inc. director Stephen Friscia received a grant of employee stock options covering 50,000 shares of common stock. The options have an exercise price of $5.00 per share and expire on April 13, 2036. All 50,000 options were held directly after the grant and are subject to expiration if he stops serving the company.
Q/C Technologies, Inc. director Chelsea Sierra Voss received an employee stock option grant covering 50,000 shares of common stock. The options have a $5.00 per share exercise price and expire on April 13, 2036. Following this grant, she holds options for 50,000 shares directly. The options may expire earlier if she stops being employed by or providing services to the company.
Q/C Technologies, Inc. reported that Chief Medical Officer Mitchell Glass received a grant of employee stock options on common stock. The award covers 50,000 options, each giving the right to buy one share of common stock at an exercise price of $5.00 per share.
These options were granted on April 13, 2026 and expire on April 13, 2036. Following this grant, Glass holds 50,000 stock options directly. The options may expire earlier if he ceases to be employed by or provide services to the company.
Q/C Technologies director Billy Joe White received a grant of employee stock options for 50,000 shares of Common Stock. The options have a conversion or exercise price of $5.00 per share, were granted on April 13, 2026, and expire on April 13, 2036. Following this award, he holds 50,000 derivative securities directly, which are subject to expiration if he stops being employed by or providing services to the company.
Q/C TECHNOLOGIES, INC. director Bruce Bernstein received an award of employee stock options covering 50,000 shares of common stock on April 13, 2026. The options have an exercise price of $5.00 per share and were granted at a price of $0.00 per option.
The options are exercisable into 50,000 shares of common stock and expire on April 13, 2036. According to the filing, the options are subject to expiration if Bernstein ceases to be employed by, or to provide services to, the company.
Q/C Technologies, Inc. reported that Executive Chairman Joshua Silverman received new equity awards. He was granted employee stock options for 100,000 shares of common stock at an exercise price of $5.00 per share, expiring on April 13, 2036, and will hold 50,000 options after this grant.
He was also awarded 162,162 shares of common stock in the form of Restricted Stock Units issued under an executive compensation agreement dated April 13, 2026. The RSUs vested immediately upon grant, bringing his direct common stock holdings to 262,191 shares.
Q/C Technologies director Chelsea Sierra Voss reported new equity awards. On January 16, 2026, she received 212,500 shares of common stock as restricted stock units under a consulting agreement and 25,000 additional RSU shares tied to her appointment to the board. Both RSU grants vest in four equal quarterly installments if she continues providing services.
She also received an employee stock option for 212,500 shares of common stock at an exercise price of $5.097 per share, vesting quarterly on the same schedule. Following these awards, she beneficially owns 239,900 shares of common stock directly and 59,802 shares indirectly through a Roth IRA, plus 212,500 stock options.
Q/C Technologies, Inc. (QCLS) reported an equity award to one of its insiders. On 11/14/2025, a director and Chief Medical Officer acquired 11,420 shares of common stock through a grant of restricted stock units at a price of $0 per share, bringing their directly held beneficial ownership to 12,500 shares. The RSUs were originally granted on 10/03/2025, subject to stockholder approval of an amendment to the company’s 2021 Equity Incentive Plan. Stockholders approved this plan amendment on 11/14/2025, and the RSUs vested immediately upon issuance.
Q/C Technologies, Inc. (QCLS) reported an equity award to a director. A board member received 22,839 shares of common stock on November 14, 2025, reported as acquired at a price of $0, bringing this person’s directly held stake to 25,024 shares after the transaction. The shares represent restricted stock units that were originally granted on October 3, 2025 under the company’s 2021 Equity Incentive Plan, subject to stockholder approval of a plan amendment. Stockholders approved that amendment on November 14, 2025, and the RSUs vested immediately upon issuance.
Q/C Technologies, Inc. (QCLS) reported an equity award to one of its directors. On November 14, 2025, the director acquired 22,839 shares of common stock at a reported price of $0, bringing the director’s beneficial ownership to 25,000 shares held directly. The filing explains that this reflects a grant of restricted stock units (RSUs) that were originally granted on October 3, 2025, subject to stockholder approval of an amendment to the company’s 2021 Equity Incentive Plan. Stockholders approved that plan amendment on November 14, 2025, and the RSUs vested immediately upon issuance on that date, resulting in the reported share ownership.
Q/C Technologies, Inc. (QCLS) reported that one of its directors acquired company stock through an equity award. On November 14, 2025, the director received 25,000 shares of common stock classified as acquired at a price of $0, held as direct ownership after the transaction. According to the explanation, this reflects a grant of Restricted Stock Units (RSUs) originally awarded on October 3, 2025, which was subject to stockholder approval of an amendment to the company’s 2021 Equity Incentive Plan. Stockholders approved the plan amendment on November 14, 2025, and the RSUs vested immediately upon issuance, resulting in the director’s beneficial ownership of these 25,000 shares.
Q/C Technologies, Inc. (QCLS) reported an insider equity award for its Vice President of Finance on a Form 4. On November 14, 2025, the executive acquired 11,420 shares of common stock at a reported price of $0 through a grant of restricted stock units (RSUs). These RSUs were originally granted on October 3, 2025, but were subject to stockholder approval of an amendment to the company’s 2021 Equity Incentive Plan, which stockholders approved on November 14, 2025, causing the RSUs to vest immediately upon issuance. Following this transaction, the reporting person directly beneficially owns 12,500 shares of Q/C Technologies common stock.